Sunday, 29 May 2022
A+ R A-

Belgian Section for Hepatobiliary and Pancreatic Surgery

  • Category: BSHBPS
  • Published: Monday, 01 September 2014 10:59
  • Written by BSHBPS Webmaster
  • 01 Sep

 

 RBSS.be - Journal

 

 

logo.png

 

                

Aim and focus

The Belgian Section of HepatoBiliary and Pancreatic Surgery - BSHBPS - aims to improve surgical education, training, research, innovation

and the quality of care for patients in the management of HPB disorders. 

 

Belgian HPB Tour 2021-2022

Candidates have been selected and will be visiting:

Dr Valerio Lucidi and Prof Desi Germanova

University Hospital Erasme-ULB
8-9 December 2021

 

Prof Thiery Chapelle and Prof Geert Roeyen:

Antwerp University Hospital
24-25 January 2022

 

Dr Claude Bertrand and Prof Alexandra Dili

CHU-UCL Namur, Site Godinne
16-17 March 2022

 

Prof Gregory Sergeant

Jessa Ziekenhuis Hasselt
4-5 May 2022

 

 

BSHBPS Board

 

 Board_21.png

 

Next meeting

Our next scientific gathering will be held during the Belgian Surgical Week.
The session is scheduled on Friday May 6th (10:00 am – 11:30 am).

Moderators: Prof. C. Hubert (Cliniques Universitaires Saint-Luc – UCLouvain), Dr. B. Van Den Bossche (ASZ)

1.       Ablation versus resection of small liver tumors

-        Pro ablation: Prof. T. Chapelle (UZA)

-        Pro resection: Dr. D. Germanova (ULB)

2.       Venous embolization  versus ALPPS in major liver resection

-        Pro embolization: Prof. A. Dili (CHU UCL Namur - site Godinne)

-        Pro ALPPS: Dr. J. Jaekers (UZ Leuven)

3.       Laparoscopic versus robotic liver resection

-        Pro laparoscopy: Dr. L. Abreu de Carvalho (UZ Gent)

-        Pro robot: Dr. V. Lucidi (ULB)

 

Previous meeting

 

21st POST GRADUATE BSHPBS COURSE  and 5th INTERNATIONAL LIVING DONOR LIVER TRANSPLANTATION CONGRESS 

"EXCELLENCE THROUGH VERSATILITY" 

October 15-16, 2021, Hotel Le Plaza, Brussels, Belgium

Register at https://www.ildlt2021.org/

 

XXthPOST GRADUATE BSHPBS COURSE - THINKING OUT OF THE BOX -

Date: Thursday, 11th MARCH 2021, from 5.00 to 8.00 pm

Format: WEBINAR HYBRID POSTGRADUATE COURSE - Recording of this webinar is now available for watching on demand. 

 

SCIENTIFIC PROGRAM

Session I: LIVER

Moderators: A. Vanlander - T. Chapelle - B. Van den Bossche 

17:00   Management of colorectal cancer with synchronous liver metastases                                                                                          D. Germanova, ULB

17:25   Management of resectable CRLM not responding to systemic chemotherapy and the role of hilar lymphadenectomy                A. Dili, CHU-UcL Namur

17:50   Minimally invasive vs open liver resections: where are we now? The Belgian experience                                                            V. Lucidi, ULB

18:20   Round table discussion

 

 

 

Session II: PANCREAS

Moderators: N. Meurisse - N. Messaoudi - F. Berrevoet - G. Roeyen 

18:30    Oligometastatic pancreatic cancer: ever candidates for resection?                                                                                               G. Sergeant, JZH Hasselt

18:55    Vascular resection in pancreatic cancer surgery                                                                                                                            J . Geers, UZ Leuven

19:20    Left Pancreatectomy                                                                                                                                                                      B. Van den Bossche, ASZ

19:45    Round table discussion

 

 

 

Ongoing research and trials

MIMIPAC-trial: Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer

This phase-2 monocenter non-randomized prospective clinical trial evaluates the effectiveness of minimally invasive microwave ablation plus immunotherapy for unresectable non-metastatic locally advanced pancreatic cancer.

Principal Investigator: Prof. Baki Topal, UZ Leuven

For registration or participation visit: https://clinicaltrials.gov/ct2/show/NCT04156087 

Contact